FDA Proposes Regulations for Rescission of Substantially Equivalent Decisions for Medical Devices

Summary

The FDA is proposing new regulations that would allow the agency to rescind decisions about medical devices that are deemed substantially equivalent to already approved devices, and also provide a process for device manufacturers to request review of these rescission decisions.